The Seventh Annual International Employment Survey

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2004
Volume 28
Issue 11

More than 1500 pharmaceutical industry employees worldwide provide a personal view into the issues that matter most in the workforce, including salary and benefits, skills and education, and perspectives on the current job market.

External Link - article-151313.pdf

Articles in this issue
Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds
The Preparation and Evaluation of Albendazole Microspheres for Colonic Delivery
In the Spotlight-December 2004
In Between the Light and the Dark: Developments in Photosensitive Pharmaceuticals
Safety Problems Roil Pharma and FDA
December 2004
Robust CRO Market Is Driving New Merger and Acquisition Activity
The Seventh Annual International Employment Survey
Pharmaco-Fakery

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

CN Bio Forms Strategic Partnership with Pharmaron to Develop OOC Technologies

Feliza Mirasol
April 25th 2025
Article

Under the partnership, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology and will integrate OOC technologies into its R&D platform.

Drug Solutions Podcast: Examining the State of Biopharma Investment

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
June 6th 2023
Podcast

In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

AstraZeneca and Alteogen Sign License Agreement for Developing Subcutaneous Formulations of Oncology Assets

Feliza Mirasol
March 25th 2025
Article

Under the agreement, AstraZeneca will use Alteogen’s proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics

Feliza Mirasol
March 24th 2025
Article

With financing led by Blue Owl Capital, Latigo will use the funds to further develop non-opioid pain treatments as well as develop other candidates in its pipeline.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset

Feliza Mirasol
March 18th 2025
Article

The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.

Young female tech or scientist performs protein assay | Image Credit: © tilialucida - stock.adobe.com

Leaving STEM Skills on the Table

Susan Haigney
February 13th 2025
Article

Investing in STEM programs for girls in an education setting and then supporting women as they excel in their professional careers is key to ensuring that vital highly skilled personnel are not left behind.